0RGI.L - Cosmo Pharmaceuticals N.V.
| Previous close | 49.90 |
| Open | 50.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 49.95 - 50.10 |
| 52-week range | 42.60 - 69.40 |
| Volume | |
| Avg. volume | 1,224 |
| Market cap | 7.358M |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | 0.38 |
| EPS (TTM) | 1.30 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Cosmo Pharmaceuticals N.V. (VTX:COPN) Is About To Go Ex-Dividend, And It Pays A 2.0% Yield
Readers hoping to buy Cosmo Pharmaceuticals N.V. ( VTX:COPN ) for its dividend will need to make their move shortly, as...
- Simply Wall St.
Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
With its stock down 17% over the past three months, it is easy to disregard Cosmo Pharmaceuticals (VTX:COPN). However...
- Simply Wall St.
Cosmo Pharmaceuticals (VTX:COPN) shareholders have endured a 58% loss from investing in the stock five years ago
Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly...
- Simply Wall St.
Cosmo Pharmaceuticals N.V.'s (VTX:COPN) P/E Still Appears To Be Reasonable
With a price-to-earnings (or "P/E") ratio of 53.2x Cosmo Pharmaceuticals N.V. ( VTX:COPN ) may be sending very bearish...
ZacksMedtronic (MDT) to Enhance AI Innovation With New Platform
Medtronic's (MDT) GI Genius intelligent endoscopy module is the first FDA-cleared, AI-assisted colonoscopy tool to help physicians detect polyps that can lead to colorectal cancer.
- Simply Wall St.
Private companies account for 46% of Cosmo Pharmaceuticals N.V.'s (VTX:COPN) ownership, while individual investors account for 36%
If you want to know who really controls Cosmo Pharmaceuticals N.V. ( VTX:COPN ), then you'll have to look at the makeup...
- Simply Wall St.
Is Cosmo Pharmaceuticals N.V.'s (VTX:COPN) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Most readers would already be aware that Cosmo Pharmaceuticals' (VTX:COPN) stock increased significantly by 20% over...
- Simply Wall St.
Cosmo Pharmaceuticals (VTX:COPN) adds €69m to market cap in the past 7 days, though investors from five years ago are still down 60%
Cosmo Pharmaceuticals N.V. ( VTX:COPN ) shareholders should be happy to see the share price up 20% in the last month...